Navigation Links
Creating Effective Cross-Functional Teams for Pharmaceutical Commercialization Success
Date:9/27/2007

ement

-- Decision-Making Processes

-- Communication and Collaboration

-- Resource Allocation

To learn more about this report including information about the research participants, key findings and sample best practices, please download a complimentary excerpt and study overview at http://www3.best-in-class.com/rr858.htm.

For questions or additional information on Best Practices, LLC's other products and services, please call Cameron Tew at 919-767-9246 or email ctew@best-in-class.com. Also, visit our Web site at http://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a research and consulting firm that conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information, call 919-403-0251 or visit http://www3.best-in-class.com/.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Creating brain cells from bone marrow
2. Creating A Greater Awareness Among Smokers
3. Doctors take part in walk: a step towards creating diabetes awareness
4. Creating Awareness about Sports Medicine
5. Innovative Method for Creating a Human Cytomegalovirus Vaccine Outlined
6. Creating Memories During Sleep
7. Overuse Of Antibiotics-Creating Monsters Out Of Common Microbes
8. Indoor Smoking Bans Creating Unhealthy Outdoor Second-hand Smoke Zones
9. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
10. Inhaled Steroids Safe & Effective for Children with Asthma
11. Morning after pill effective up to five days after having unprotected sex
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 2Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 3Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 4Advisory Committee Briefing Materials for CRESTOR(R) sNDA Available on US FDA Web Site 5Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Combo Therapies to Lower Cholesterol Dont Work 56054 1Combo Therapies to Lower Cholesterol Dont Work 56054 2Wounded Warrior Project to Participate in BGC Partners Annual Charity Day 56052 1Wounded Warrior Project to Participate in BGC Partners Annual Charity Day 56052 2Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinsons Disease 13806 1Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinsons Disease 13806 2Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinsons Disease 13806 3Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinsons Disease 13806 4